Jundishapur Journal of Microbiology

Published by: Kowsar

Enhancement of Hepatitis E Virus DNA Vaccine Immunity by Beclin-1- Mediated Autophagy

Hamed Naziri 1 , Asghar Abdoli 2 , Amir Ghaemi 3 , Fatemeh Motevalli 2 , Parviz Owlia 4 , Mostafa Ghanei 5 , Golnaz Bahramali 2 , Vahid Salimi 1 , Mohammad Reza Aghasadeghi 2 and Jila Yavarian 1 , *
Authors Information
1 Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran
3 Department of Virology, Institute Pasteur of Iran, Tehran, Iran
4 Molecular Microbiology Research Center (MMRC), Faculty of Medicine, Shahed University, Tehran, Iran
5 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
Article information
  • Jundishapur Journal of Microbiology: December 2017, 10 (12); e57474
  • Published Online: November 21, 2017
  • Article Type: Research Article
  • Received: July 3, 2017
  • Revised: September 8, 2017
  • Accepted: September 18, 2017
  • DOI: 10.5812/jjm.57474

To Cite: Naziri H, Abdoli A, Ghaemi A, Motevalli F, Owlia P, et al. Enhancement of Hepatitis E Virus DNA Vaccine Immunity by Beclin-1- Mediated Autophagy, Jundishapur J Microbiol. 2017 ; 10(12):e57474. doi: 10.5812/jjm.57474.

Abstract
Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
Acknowledgements
Footnotes
References
  • 1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095-128[DOI][PubMed]
  • 2. Taherkhani R, Farshadpour F. Epidemiology of Hepatitis E in Pregnant Women and Children in Iran: A General Overview. J Clin Transl Hepatol. 2016; 4(3): 269-76[DOI][PubMed]
  • 3. Naziri H, Tahamtan A, Moradi A, Tabarraei A. Evaluation of anti-hepatitis E virus antibody among hemodialysis patients in Gorgan, north of Iran. Iran J Virol. 2016; 10(2-3): 13-8
  • 4. Sridhar S, Teng JLL, Chiu TH, Lau SKP, Woo PCY. Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants. Int J Mol Sci. 2017; 18(4)[DOI][PubMed]
  • 5. Zhou YH, Purcell RH, Emerson SU. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine. 2004; 22(20): 2578-85[DOI][PubMed]
  • 6. Li SW, Zhang J, Li YM, Ou SH, Huang GY, He ZQ, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine. 2005; 23(22): 2893-901[DOI][PubMed]
  • 7. Shrestha MP, Scott RM, Joshi DM, Mammen MJ, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007; 356(9): 895-903[DOI][PubMed]
  • 8. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010; 376(9744): 895-902[DOI][PubMed]
  • 9. Zhao Q, Zhang J, Wu T, Li SW, Ng MH, Xia NS, et al. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. J Gastroenterol. 2013; 48(2): 159-68[DOI][PubMed]
  • 10. Sajadian A, Tabarraei A, Soleimanjahi H, Fotouhi F, Gorji A, Ghaemi A. Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine. Arch Virol. 2014; 159(8): 1951-60[DOI][PubMed]
  • 11. Saeedi A, Ghaemi A, Tabarraei A, Moradi A, Gorji A, Semnani S, et al. Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice. Virus Genes. 2014; 49(1): 11-21[DOI][PubMed]
  • 12. Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe. 2009; 5(6): 527-49[DOI][PubMed]
  • 13. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011; 469(7330): 323-35[DOI][PubMed]
  • 14. Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity. 2007; 26(1): 79-92[DOI][PubMed]
  • 15. Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta. 2009; 1793(4): 664-73[DOI][PubMed]
  • 16. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011; 18(4): 571-80[DOI][PubMed]
  • 17. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999; 402(6762): 672-6[DOI][PubMed]
  • 18. Schmid D, Munz C. Innate and adaptive immunity through autophagy. Immunity. 2007; 27(1): 11-21[DOI][PubMed]
  • 19. Munz C. Beclin-1 targeting for viral immune escape. Viruses. 2011; 3(7): 1166-78[DOI][PubMed]
  • 20. Hong Y, Ruan B, Yang LH, Chen Y, Jing L, Wang YT, et al. Hepatitis E virus chimeric DNA vaccine elicits immunologic response in mice. World J Gastroenterol. 2005; 11(42): 6713-5[DOI][PubMed]
  • 21. Dengjel J, Schoor O, Fischer R, Reich M, Kraus M, Muller M, et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A. 2005; 102(22): 7922-7[DOI][PubMed]
  • 22. Andersen AN, Landsverk OJ, Simonsen A, Bogen B, Corthay A, Oynebraten I. Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity. Front Immunol. 2016; 7: 167[DOI][PubMed]
  • 23. Wu T, Li SW, Zhang J, Ng MH, Xia NS, Zhao Q. Hepatitis E vaccine development: a 14 year odyssey. Hum Vaccin Immunother. 2012; 8(6): 823-7[DOI][PubMed]
  • 24. Li S, Zhang J, Xia N. Lessons from hepatitis E vaccine design. Curr Opin Virol. 2015; 11: 130-6[DOI][PubMed]
  • 25. Wu T, Wu XL, Ou SH, Lin CX, Cheng T, Li SW, et al. Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity. Mol Immunol. 2007; 44(12): 3261-6[DOI][PubMed]
  • 26. Taherkhani R, Farshadpour F, Makvandi M, Rajabi Memari H, Samarbafzadeh AR, Sharifi N, et al. Cytokine Profiles and Cell Proliferation Responses to Truncated ORF2 Protein in Iranian Patients Recovered from Hepatitis E Infection. J Trop Med. 2015; 2015: 523560[DOI][PubMed]
  • 27. Tuteja R, Li TC, Takeda N, Jameel S. Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes. Viral Immunol. 2000; 13(2): 169-78[DOI][PubMed]
  • 28. Munz C. Antigen processing for MHC presentation by autophagy. F1000 Biol Rep. 2010; 2: 61[DOI][PubMed]
  • 29. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol. 2009; 10(5): 480-7[DOI][PubMed]
  • 30. Meerak J, Wanichwecharungruang SP, Palaga T. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. Vaccine. 2013; 31(5): 784-90[DOI][PubMed]
  • 31. Hu D, Wu J, Zhang R, Chen L, Chen Z, Wang X, et al. Autophagy-targeted vaccine of LC3-LpqH DNA and its protective immunity in a murine model of tuberculosis. Vaccine. 2014; 32(20): 2308-14[DOI][PubMed]
  • 32. He J, Hayes CG, Binn LN, Seriwatana J, Vaughn DW, Kuschner RA, et al. Hepatitis E virus DNA vaccine elicits immunologic memory in mice. J Biomed Sci. 2001; 8(2): 223-6[PubMed]
  • 33. Yang S, Wang C, Fang X, Zhai L, Dong C, Ding L, et al. Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization. Virus Res. 2010; 151(2): 162-9[DOI][PubMed]
  • 34. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008; 28(9): 1190-9[DOI][PubMed]
  • 35. Taherkhani R, Farshadpour F, Makvandi M. Design and production of a multiepitope construct derived from hepatitis E virus capsid protein. J Med Virol. 2015; 87(7): 1225-34[DOI][PubMed]
  • 36. Farshadpour F, Makvandi M, Taherkhani R. Design, Construction and Cloning of Truncated ORF2 and tPAsp-PADRE-Truncated ORF2 Gene Cassette From Hepatitis E Virus in the pVAX1 Expression Vector. Jundishapur J Microbiol. 2015; 8(12)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments